D. Lynn Kirkpatrick
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Biochemistry top 5%
- Sulfur Compounds in Biology
Papers in
-
- Redox biology and oxidative stress 10
- Glutathione Transferases and Polymorphisms 6
- PI3K/AKT/mTOR signaling in cancer 6
- Genomics, phytochemicals, and oxidative stress 5
-
- Sulfur Compounds in Biology 7
- Co-authors
- Garth Powis (16 shared papers)Sarah J. Welsh (2 shared papers)Ryan Williams (2 shared papers)Amanda F. Baker (5 shared papers)Nathan T. Ihle (6 shared papers)M. Martín Angulo (3 shared papers)Peter Wipf (2 shared papers)David Newman (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (3 papers)Biochemical Pharmacology (3 papers)Cancer Research (3 papers)Clinical Cancer Research (2 papers)Leukemia Research (2 papers)
- Partner nations
- United StatesCanada
In The Last Decade
D. Lynn Kirkpatrick
33 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 104
- Cancer Research 436
- Biochemistry 146
- Molecular Biology 1.4k
- Toxicology 43
- Oncology 282
Countries citing papers authored by D. Lynn Kirkpatrick
This map shows the geographic impact of D. Lynn Kirkpatrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Lynn Kirkpatrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Lynn Kirkpatrick more than expected).
Fields of papers citing papers by D. Lynn Kirkpatrick
This network shows the impact of papers produced by D. Lynn Kirkpatrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Lynn Kirkpatrick. The network helps show where D. Lynn Kirkpatrick may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Lynn Kirkpatrick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 242 | |
| 2 | 2008 | 225 | |
| 3 | 2007 | 220 | |
| 4 | The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1alpha and vascular endothelial growth factor formation. | 2003 | 216 |
| 5 | 2005 | 126 | |
| 6 | 1998 | 118 | |
| 7 | 1998 | 87 | |
| 8 | 2007 | 85 | |
| 9 | 2006 | 77 | |
| 10 | 2010 | 66 | |
| 11 | 1996 | 59 | |
| 12 | Selenium and the thioredoxin redox system: effects on cell growth and death. | 1997 | 57 |
| 13 | 2012 | 44 | |
| 14 | 2016 | 38 | |
| 15 | 1990 | 37 | |
| 16 | 2006 | 33 | |
| 17 | 2019 | 27 | |
| 18 | 1999 | 20 | |
| 19 | 1992 | 16 | |
| 20 | 1986 | 16 |
About D. Lynn Kirkpatrick
D. Lynn Kirkpatrick is a scholar working on Molecular Biology, Biochemistry, Cancer Research, Organic Chemistry and Genetics, having authored 34 papers that have together received 1.8k indexed citations. Recurring topics across this work include Redox biology and oxidative stress (10 papers), Sulfur Compounds in Biology (7 papers), Glutathione Transferases and Polymorphisms (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Genomics, phytochemicals, and oxidative stress (5 papers), Computational Drug Discovery Methods (3 papers) and Free Radicals and Antioxidants (3 papers). The work is most often cited by research in Cancer Research (436 citations), Biochemistry (146 citations), Molecular Biology (1.4k citations), Toxicology (43 citations) and Oncology (282 citations). D. Lynn Kirkpatrick has collaborated with scholars based in United States and Canada. Frequent co-authors include Garth Powis, Sarah J. Welsh, Ryan Williams, Amanda F. Baker, Nathan T. Ihle, M. Martín Angulo, Peter Wipf, David Newman, Anne Birmingham and Mei Yee Koh. Their work appears in journals such as Molecular Cancer Therapeutics, Biochemical Pharmacology, Cancer Research, Clinical Cancer Research and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.